Liquid versus tissue biopsy for detecting actionable alterations according to ESCAT in patients with advanced cancer: A study from the French National Center for Precision Medicine (PRISM)

Liquid versus tissue biopsy for detecting actionable alterations according to ESCAT in patients with advanced cancer: A study from the French National Center for Precision Medicine (PRISM)

A Bayle, F Peyraud, L Belcaid, M Brunet, M Aldea, R Clodion, P Dubos, D Vasseur, C Nicotra, A Geraud, M Sakkal, L Cerbone, F Blanc-Durand, F Mosele, P Martin Romano, M Ngo Camus, I Soubeyran, E Khalifa, M Alame, L Blouin, D Dinart, C Bellera, A Hollebecque, S Ponce, Y...